Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Wockhardt Ltd.

Price on BSE   03 Sep,15:29 LIVE
1,955.00
+50.25
(+2.64%)

© 2026 Rediff.com
  • Volume :
  • 144,872.00
  • Prev Close :
  • 1,904.75
  • Day's H/L (Rs.) :
  • 1,980.00 - 1,890.80
  • 52wk H/L (Rs.) :
  • 2,420.00 - 1,086.80
  • Mkt Cap (Rs. Cr) :
  • 31,768.75
Price on NSE   03 Sep,15:58 LIVE
1,950.60
+46.30
(+2.43%)

© 2026 Rediff.com
  • Volume :
  • 1,056,400.00
  • Prev Close :
  • 1,904.30
  • Day's H/L (Rs.) :
  • 1,982.00 - 1,891.40
  • 52wk H/L (Rs.) :
  • 2,422.30 - 1,086.70
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Can Headaches Be A Sign Of Brain Tumour?
Rediff.com   08 Jun 2026
Report Card - Wockhardt Ltd.
PE Ratios
99.93
EPS (Rs.)
19.56
Sales (Rs. Cr)
561.00
Face Value (Rs.)
5
Net Profit Margin(%)
18.22
Last Bonus
1:2
Last Dividend(%)
200
Return on Average Equity
10.27

News for Wockhardt Ltd.

Wockhardt Ltd Reports Rs 107 Cr Q1 Profit After Tax
Wockhardt Ltd announced a consolidated profit after tax of Rs 107 crore for Q1 ended June 30, driven by strong revenue growth. Company turned profitable from a loss.
Aug 10, 2026 15:57
Wockhardt UTI Drug Zaynich Approved in India
Wockhardt receives CDSCO approval to market Zaynich, a new antibiotic for complicated UTIs, including kidney infections, in India.
May 28, 2026 16:27
Wockhardt Zaynich Antibiotic Gets CDSCO Approval
Wockhardt receives CDSCO approval for Zaynich (Zidebactam/Cefepime) antibiotic for complicated urinary tract infections in India.
May 28, 2026 11:30
Wockhardt Posts Rs 164 Cr Profit in Jan-Mar Quarter
Wockhardt Ltd reports Rs 164 crore net profit in Q4 ended March 31, 2026, against a loss last year. Revenue rises to Rs 965 crore.
May 04, 2026 16:21
Wockhardt Q3 Profit Jumps 3x to Rs 61 Cr
Wockhardt's Q3 profit after tax surged threefold to Rs 61 crore. Revenue rose to Rs 888 crore. Upcoming insulin analogs launch is a key opportunity.
Feb 10, 2026 17:38

More News for Wockhardt Ltd. »

About Wockhardt Ltd.

Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. Wikipedia

News for Pharmaceuticals

Cipla & Qilu Partner for Keytruda Biosimilar in US
Cipla's Invagen partners with Qilu Pharmaceutical to launch a Keytruda (pembrolizumab) biosimilar in the US, aiming to lower cancer treatment costs.
Sep 04, 2026 00:07
Goyal: India's Sensitivities Uncompromised in US Trade Pact
Commerce Minister Piyush Goyal assures that no Indian sensitivities were compromised in the US trade agreement, despite details not being public. Consultations held.
Sep 03, 2026 21:56
Ashok Leyland MD Shenu Agarwal Elected SIAM President
Ashok Leyland MD & CEO Shenu Agarwal elected SIAM President for 2026-27. K N Radhakrishnan is VP, Santosh Iyer is Treasurer.
Sep 03, 2026 21:51
Sebi to Review Derivative Settlement Price After CAS Rollout
Sebi plans to review the methodology for derivative contract settlement prices at expiry, following concerns after the Closing Auction Session (CAS) rollout.
Sep 03, 2026 21:46
Banking System Liquidity Hits Record High on FCNR(B) Flows
India's banking system liquidity surplus reached a record Rs 9.71 lakh crore, driven by FCNR(B) inflows. RBI may use VRRR auctions or ICRR to manage.
Sep 03, 2026 21:46

More News »

Top News

Cipla & Qilu Partner for Keytruda Biosimilar in US
Cipla's Invagen partners with Qilu Pharmaceutical to launch a Keytruda (pembrolizumab) biosimilar in the US, aiming to lower cancer treatment costs.
Sep 04, 2026 00:07
South Africa-India Boost Economic Ties, Address Trade Deficit
A South African delegation visits India to expand economic ties, address trade imbalance, and seek investment in manufacturing, pharma, and green energy.
Sep 04, 2026 00:02
Aaditya Thackeray Questions GDP Growth, Job Creation
Aaditya Thackeray challenges India's 7.8% GDP growth, questioning job creation and economic reflection. He also comments on Maratha quota and farmer issues.
Sep 03, 2026 22:49
Gujarat Bets on AI, Semiconductors, Green Energy for Growth
Gujarat shifts focus to new-age sectors like AI, semiconductors, and green energy, aiming for a $3.5 trillion economy by 2047. CM Patel highlights futuristic development.
Sep 03, 2026 22:47
Tea Board, ISRO, NIT Partner for AI Tea Monitoring System
Tea Board, ISRO, and NIT Rourkela launch 'CHAAYANKAN,' an AI-based system using satellite & UAV data for tea plantation monitoring, pest management, and yield estimation.
Sep 03, 2026 22:05

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com